Position
Chief Business Officer
Company
SynAct Pharma
LundBiotechnologyHealth CareresearchDescription
SynAct Pharma AB has appointed Mads Bjerregaard as its new Chief Business Officer, succeeding Jim Knight. This strategic move comes as SynAct is at a pivotal stage with its Phase 2b ADVANCE study for rheumatoid arthritis and aims to enhance commercial prospects.
Other recent leadership changes in research and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Allegro NV Appoints Stephan Crokaert as Chief Operating Officer (September 3, 2025)
- Sitryx Appoints Adam Mostafa as Chief Financial Officer (September 8, 2025)
- Nuvig Therapeutics Appoints David J. Woodhouse as Chief Executive Officer (September 9, 2025)
- Exelixis Appoints Dana T. Aftab, Ph.D. as Executive Vice President of Research and Development (August 29, 2025)
- Altimmune Appoints Linda M. Richardson as Chief Commercial Officer (September 15, 2025)
- GAIASO Theranostics Appoints Dr Tracey Brown as Chief Executive Officer (September 16, 2025)
Who to call at SynAct Pharma, and when
A new leader at SynAct Pharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day SynAct Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SynAct Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SynAct Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SynAct Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
SynAct Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.